These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25427395)

  • 1. [The treatment of rheumatoid arthritis].
    Babić-Naglić D
    Reumatizam; 2014; 61(2):55-9. PubMed ID: 25427395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.
    van der Woude D; Young A; Jayakumar K; Mertens BJ; Toes RE; van der Heijde D; Huizinga TW; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2262-71. PubMed ID: 19644846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment and management of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis.
    Feely MG; O'Dell JR
    Curr Opin Rheumatol; 2010 May; 22(3):316-20. PubMed ID: 20190639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Discontinuation or tapering strategies of biologics in rheumatoid arthritis in remission].
    Mallick A; Fautrel B; Sagez F; Sordet C; Javier RM; Petit H; Chatelus E; Rahal N; Gottenberg JE; Sibilia J
    Rev Med Interne; 2017 Apr; 38(4):256-263. PubMed ID: 28161110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial management of rheumatoid arthritis.
    Gramling A; O'Dell JR
    Rheum Dis Clin North Am; 2012 May; 38(2):311-25. PubMed ID: 22819086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex: a major predictor of remission in early rheumatoid arthritis?
    Forslind K; Hafström I; Ahlmén M; Svensson B;
    Ann Rheum Dis; 2007 Jan; 66(1):46-52. PubMed ID: 17158139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of biological agents in treatment of rheumatoid arthritis.
    Law ST; Taylor PC
    Pharmacol Res; 2019 Dec; 150():104497. PubMed ID: 31629903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The goal for the treatment of rheumatoid arthritis should be remission].
    Möttönen T; Mäkinen H; Puolakka K
    Duodecim; 2010; 126(12):1457-64. PubMed ID: 20617749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up.
    Verstappen SM; van Albada-Kuipers GA; Bijlsma JW; Blaauw AA; Schenk Y; Haanen HC; Jacobs JW;
    Ann Rheum Dis; 2005 Jan; 64(1):38-43. PubMed ID: 15130899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis.
    Sandberg ME; Bengtsson C; Källberg H; Wesley A; Klareskog L; Alfredsson L; Saevarsdottir S
    Ann Rheum Dis; 2014 Nov; 73(11):2029-33. PubMed ID: 24818635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
    Ciubotariu E; Gabay C; Finckh A;
    J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study.
    Vermeer M; Kuper HH; Hoekstra M; Haagsma CJ; Posthumus MD; Brus HL; van Riel PL; van de Laar MA
    Arthritis Rheum; 2011 Oct; 63(10):2865-72. PubMed ID: 21647867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovative treatment strategies for patients with rheumatoid arthritis.
    van der Kooij SM; Allaart CF; Dijkmans BA; Breedveld FC
    Curr Opin Rheumatol; 2008 May; 20(3):287-94. PubMed ID: 18388520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinations of second-line drugs for rheumatoid arthritis: is remission induction a reasonable goal?
    Le Loët X; Vittecoq O; Daragon A
    Rev Rhum Engl Ed; 1998 Mar; 65(3):161-4. PubMed ID: 9574472
    [No Abstract]   [Full Text] [Related]  

  • 16. Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial.
    Hørslev-Petersen K; Hetland ML; Junker P; Pødenphant J; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Horn HC; Ammitzbøll CG; Jørgensen A; Krintel SB; Raun J; Johansen JS; Østergaard M; Stengaard-Pedersen K;
    Ann Rheum Dis; 2014 Apr; 73(4):654-61. PubMed ID: 23434570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [112th Scientific Meeting of the Japanese Society of Internal Medicine: Presidential Lecture: Invited Lecture: Progress in Rheumatoid Arthritis Therapy and Future Perspective].
    Takeuchi T
    Nihon Naika Gakkai Zasshi; 2015 Sep; 104(9):1773-82. PubMed ID: 30160862
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry.
    Hetland ML; Christensen IJ; Tarp U; Dreyer L; Hansen A; Hansen IT; Kollerup G; Linde L; Lindegaard HM; Poulsen UE; Schlemmer A; Jensen DV; Jensen S; Hostenkamp G; Østergaard M;
    Arthritis Rheum; 2010 Jan; 62(1):22-32. PubMed ID: 20039405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining best practices in early rheumatoid arthritis by comparing differences in treatment at sites in the Canadian Early Arthritis Cohort.
    Harris JA; Bykerk VP; Hitchon CA; Keystone EC; Thorne JC; Boire G; Haraoui B; Hazlewood G; Bonner AJ; Pope JE;
    J Rheumatol; 2013 Nov; 40(11):1823-30. PubMed ID: 24037554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to use biologic agents in patients with rheumatoid arthritis who have comorbid disease.
    Richards JS; Dowell SM; Quinones ME; Kerr GS
    BMJ; 2015 Aug; 351():h3658. PubMed ID: 26282936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.